IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020November 23, 2020 by Alejandro
IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients November 23, 2020November 23, 2020 by Alejandro
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients August 20, 2020 by Alejandro
IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders May 8, 2020 by Alejandro
IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals March 26, 2020March 27, 2020 by charlie
IGC Reports Financial Results for the Quarter Ended December 31st, 2019 February 11, 2020February 11, 2020 by charlie
